IBB Holdings Information

IBB is an equity ETF with a total of 254 individual holdings. The top holdings are Gilead Sciences stock at 7.82%, Vertex Pharmaceuticals at 7.67%, Amgen at 7.47%, Alnylam Pharmaceuticals at 5.65%, and Regeneron Pharmaceuticals at 5.51%.

Total Holdings

Top 10 Percentage

48.76%

Asset Class

Equity

ETF Category

Health

Assets

6.57B

PE Ratio

19.75

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	7.82%	4,188,257
2	VRTX	Vertex Pharmaceuticals Incorporated	7.67%	1,210,027
3	AMGN	Amgen Inc.	7.47%	1,644,517
4	ALNY	Alnylam Pharmaceuticals, Inc.	5.65%	770,781
5	REGN	Regeneron Pharmaceuticals, Inc.	5.51%	627,147
6	ARGX	argenx SE	3.39%	264,169
7	IQV	IQVIA Holdings Inc.	3.22%	1,034,872
8	INSM	Insmed Incorporated	3.20%	1,269,335
9	MTD	Mettler-Toledo International Inc.	2.58%	125,583
10	NTRA	Natera, Inc.	2.24%	812,437
11	BIIB	Biogen Inc.	1.95%	898,616
12	WAT	Waters Corporation	1.86%	364,736
13	ONC	BeOne Medicines AG	1.84%	382,541
14	UTHR	United Therapeutics Corporation	1.77%	268,643
15	INCY	Incyte Corporation	1.58%	1,184,752
16	GMAB	Genmab A/S	1.40%	2,780,460
17	ILMN	Illumina, Inc.	1.33%	917,579
18	NBIX	Neurocrine Biosciences, Inc.	1.26%	592,516
19	MEDP	Medpace Holdings, Inc.	1.12%	139,315
20	IONS	Ionis Pharmaceuticals, Inc.	1.08%	970,691
21	EXEL	Exelixis, Inc.	0.96%	1,600,533
22	BMRN	BioMarin Pharmaceutical Inc.	0.94%	1,161,398
23	TECH	Bio-Techne Corporation	0.89%	944,083
24	ASND	Ascendis Pharma A/S	0.84%	262,361
25	MRNA	Moderna, Inc.	0.83%	2,109,628

As of Oct 17, 2025

Showing 25 of 254 holdings

Subscribe to see the full list

Activate Now

As of Oct 17, 2025